Role of ursodeoxycholic acid in lowering ALT in chronic liver disease.
The objective was to see the efficacy of ursodeoxycholic acid in improving the ALT levels in patients suffering from chronic liver disease. Thirty patients suffering from chronic liver disease (either B or C) were given oral ursodeoxycholic acid in a dose of 250 mg twice a day for 4 months. Their blood biochemistry and haematology were repeated monthly for 7 months i.e. 4 months of therapy and 3 months post therapy to see the response. The mean ALT levels of 30 patients who completed the study was 101 +/- 47 IU/L. During therapy 24 cases (80%) showed lowering of their ALT levels while 6 (20%) either showed no response or worsening of ALT levels. Of 24 cases who showed an improvement in their ALT levels; over 25% drop in ALT levels was seen in 217 cases (70%) and less than 25% drop seen in 7 cases (30%). The mean ALT values during therapy were 75 IU/L showing an overall 25% reduction from the baseline values. Following cessation of therapy the mean ALT levels showed a rise to 90 IU/L which was almost similar to 101 IU/L value in the pre treatment period. The study showed some role of ursodeoxycholic acid in improving the ALT levels in chronic liver disease.
Qureshi
Huma
H
Pakistan Medical Research Council, Research Centre, Jinnah Postgraduate Medical Centre, Karachi.
Mehdi
Itrat
I
Ahmed
Waquar Uddin
WU
Alam
Syed Ejaz
SE
D000284:Administration, Oral; D000328:Adult; D000410:Alanine Transaminase / Q000187:drug effects*; D005260:Female; D019694:Hepatitis B, Chronic / Q000201:enzymology*; D019698:Hepatitis C, Chronic / Q000201:enzymology*; D006801:Humans; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage / Q000494:pharmacology*
D014580:Ursodeoxycholic Acid; D000410:Alanine Transaminase